| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
PsoriasisAdalimumabCrohn s diseaseAsthma (BASKET)Inflammatory bowel diseasesTuberculosis| 1 | 2009 | Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature. | 
| + | - | nl | Biologics 3(-):303-18 (2009) |
| 2 | 2008 | Adalimumab for the treatment of Crohn's disease. |
| + | - | nl | Biologics 2(4):763-77 (2008) |
| 3 | 2009 | Adalimumab for the treatment of psoriasis. |
| + | - | nl | Health Technol Assess 13 Suppl 2():49-54 (2009) Turner D |
| 4 | 2009 | Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. |
| + | - | nl | Ann Rheum Dis 68(12):1863-9 (2009) |
| 5 | 2006 | Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab. |
| + | - | nl | Ann Rheum Dis 65(6):839-40 (2006) |
| 6 | 2009 | Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab. |
| + | - | nl | Aliment Pharmacol Ther 30(10):977-86 (2009) |
| 7 | 2009 | Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients. |
| + | - | nl | Aliment Pharmacol Ther 29(3):273-8 (2009) |
| 8 | 2010 | Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. |
| + | - | nl | Ann Rheum Dis 69(2):394-9 (2010) |
| 9 | 2009 | Adalimumab treatment of life-threatening tuberculosis. |
| + | - | nl | Clin Infect Dis 48(10):1429-32 (2009) |
